New drugs effective at treating hepatitis C, but at a price
PROVIDENCE, R.I. (AP) - Rhode Island Department of Corrections officials say that new drugs are effective at treating hepatitis C. But their steep price has made it difficult to decide when to treat inmates and how to pay for their care. The Providence ...
Turn to 10 - Mon, 20 Apr 2015 00:30

New hepatitis C treatment far too expensive for RI prisons
The Providence Journal - Sun, 19 Apr 2015 22:37

Gilead Sciences: Why Nomura Sees Upside in Hepatitis C
Nomura's M. Ian Somaiya and team explain think Gilead Sciences' (GILD) revenues from its hepatitis-c treatments will surprise folks. They explain why: Gilead Sciences. Our analysis of IMS scrip data points to upside in Gilead's HCV franchise, with 1Q ...
Barron's (blog) - Mon, 20 Apr 2015 08:14

Morningstar: Gilead Sciences To Grow Its Hepatitis C Market
Benzinga - Sat, 18 Apr 2015 08:22

Gilead Sciences (GILD) Stock Holders...Get Ready For Big Gains!
CNA Finance (press release) - Mon, 20 Apr 2015 11:21

Here's How Gilead Sciences, Inc. (GILD) Will Surpass Expectations For Q12015
Bidness ETC - Mon, 20 Apr 2015 08:11

Ignore These Risks to Gilead at Your Peril
Investopedia - Mon, 20 Apr 2015 08:56

Gilead Sciences: Serious Cash Means An Acquisition Could Be Coming Soon ...
Seeking Alpha - Mon, 20 Apr 2015 12:07

3 Drug Stocks Leading the Charge Against Infectious Diseases
Motley Fool - Sat, 18 Apr 2015 11:56

Hepatitis C fears: Should I Worry?
If this error is occurring repeatedly, we may be experiencing technical difficulties. We apologize for the inconvenience. Refresh Browser. Error Code: 400-101. b0de6eef-dad7-30d2-ba3d-1c2021e7a558. Hepatitis C fears: Should I Worry? Now watching.  
Yahoo News - Sun, 19 Apr 2015 11:03

Hepatitis C Will Share Spotlight This Year at Liver Congress
Hepatitis C will again be a hot topic at this year's European Association for the Study of the Liver (EASL) International Liver Congress, but other subjects, such as nonalcoholic fatty liver disease, hepatocellular carcinoma, and noninvasive liver ...
Medscape - Fri, 17 Apr 2015 05:22

The Best Stock to Invest in Hep C
The market for hepatitis C treatment is among the most lucrative for drugmakers, but it's also one of the most dynamically changing markets. Only 10 years ago, patients were treated with side effect-laden cocktails of drugs that offered coin-flip cure ...
Motley Fool - Thu, 16 Apr 2015 05:00

New hepatitis C drugs are costing Medicare billions
Medicare spent $4.5 billion last year on new, pricey medications that cure the liver disease hepatitis C — more than 15 times what it spent the year before on older treatments for the disease, previously undisclosed federal data shows. The ...
Washington Post - Sun, 29 Mar 2015 19:02

The Cost of a Cure: Medicare Spent $4.5 Billion on New Hepatitis C Drugs Last ...
ProPublica - Sun, 29 Mar 2015 19:03

Medicare spending on hepatitis C drugs soared 15-fold in 2014
RT - Mon, 30 Mar 2015 11:30

New hepatitis C drugs costing Medicare billions
Dallas Morning News - Sun, 29 Mar 2015 21:02

New hepatitis C drugs cost Medicare billions - Mon, 30 Mar 2015 07:22

New hepatitis C drugs cost government $4.5B
The Hill - Mon, 30 Mar 2015 05:53

Medicare Spending on Hepatitis C Prescription Drugs Jumps in 2014
California Healthline - Mon, 30 Mar 2015 08:00

Could An Allergy Drug Treat Hepatitis C?
An over-the-counter drug commonly used to treat allergies may one day also contribute to the treatment of hepatitis C, according to new research in mice published in the journal Science Translational Medicine.
TIME - Wed, 08 Apr 2015 11:01

Cheap allergy drug may be effective for hepatitis C
CBS News - Wed, 08 Apr 2015 12:24

Cheap Allergy Drug May Hold Potential as Hepatitis C Treatment – WebMD
WebMD - Wed, 08 Apr 2015 12:52

Allergy drug inhibits hepatitis C in mice
National Institutes of Health (press release) - Wed, 08 Apr 2015 11:00

Forget $1000 A Dose Hepatitis C Drug: This Cheap Allergy Medicine Might Be ...
Tech Times - Thu, 09 Apr 2015 05:38

Allergy Medicine Prevents Early Stage Of Hepatitis C In Mice, Considered ...
Medical Daily - Thu, 09 Apr 2015 10:00

Cepheid Gets CE Mark for Hepatitis C Viral Load Test
NEW YORK (GenomeWeb) – Cepheid said today that it has received a CE IVD mark for Xpert HCV Viral Load, a test that provides quantitative, on-demand confirmation of infection and monitoring of hepatitis C virus. The test is intended for use as an aid in ...
GenomeWeb - Wed, 15 Apr 2015 06:41

1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014